相互作用
Buprenorphine long-acting + Ethosuximide
重症度: 重大
Buprenorphine long-acting and Ethosuximide: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Concurrent use of long-acting injectable buprenorphine with a CNS depressant such as ethosuximide increases the risk of sedation and respiratory depression. The depot effect means the opioid cannot be quickly withdrawn if problems occur.
この相互作用をわかりやすく説明すると
Buprenorphine long-acting and Ethosuximide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
なぜ起こるのか
Additive CNS and respiratory depression.
対処法
Monitor for oversedation and respiratory depression, particularly after injection and with ethosuximide dose changes. Avoid additional sedatives and alcohol.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Buprenorphine long-actingとEthosuximideの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Ethosuximideのその他の相互作用
- Benzhydrocodone / acetaminophen + Ethosuximide 重大
- Buprenorphine subdermal implant + Ethosuximide 重大
- Buprenorphine transdermal + Ethosuximide 重大
- Calcium / magnesium / potassium / sodium oxybates + Ethosuximide 重大
- Ethosuximide + Fentanyl intranasal 重大
- Ethosuximide + Fentanyl iontophoretic transdermal system 重大
よくある質問
Can I take Buprenorphine long-acting with Ethosuximide?
MediHelp rates the interaction as major. Buprenorphine long-acting and Ethosuximide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Concurrent use of long-acting injectable buprenorphine with a CNS depressant such as ethosuximide increases the risk of sedation and respiratory depression. The depot effect means the opioid cannot be quickly withdrawn if problems occur.
How serious is the interaction between Buprenorphine long-acting and Ethosuximide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for oversedation and respiratory depression, particularly after injection and with ethosuximide dose changes. Avoid additional sedatives and alcohol.
What other medicines interact with Ethosuximide?
MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine subdermal implant, Buprenorphine transdermal. The full list is on the Ethosuximide page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
